Close Menu

NEW YORK – T2 Biosystems reported after the close of the market on Monday that its fourth quarter revenues rose 71 percent year over year.

For the three months ended Dec. 31, 2019, the company posted revenues of $3.1 million, lower than analysts' average estimate of $3.7 million. Product revenues were up 18 percent year over year at $1.6 million, and the firm's research revenues doubled to $1.5 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.